Diffuse PRAME expression is highly specific for malignant melanoma in the distinction from clear cell sarcoma

J Cutan Pathol. 2020 Dec;47(12):1226-1228. doi: 10.1111/cup.13812. Epub 2020 Sep 10.

Authors

Shyam S Raghavan¹, Jennifer Y Wang^{1

2}, Angus Toland¹, Charles D Bangs¹, Kerri E Rieger^{1

2}, Roberto A Novoa^{1

2}, Gregory W Charville¹, Ryanne A Brown^{1

2

3}

Affiliations

¹ Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
² Department of Dermatology, Stanford University School of Medicine, Stanford, California, USA.
³ Department of Pathology, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.

PMID: 32681554
DOI: 10.1111/cup.13812

No abstract available

MeSH terms

Antigens, Neoplasm / analysis
Antigens, Neoplasm / biosynthesis*
Biomarkers, Tumor / analysis
Biomarkers, Tumor / metabolism
Diagnosis, Differential
Humans
Melanoma / diagnosis*
Melanoma, Cutaneous Malignant
Sarcoma, Clear Cell / diagnosis*
Sensitivity and Specificity
Skin Neoplasms / diagnosis*

Substances

Antigens, Neoplasm
Biomarkers, Tumor
PRAME protein, human